MXPA05002080A - Agonistas muscarinicos. - Google Patents
Agonistas muscarinicos.Info
- Publication number
- MXPA05002080A MXPA05002080A MXPA05002080A MXPA05002080A MXPA05002080A MX PA05002080 A MXPA05002080 A MX PA05002080A MX PA05002080 A MXPA05002080 A MX PA05002080A MX PA05002080 A MXPA05002080 A MX PA05002080A MX PA05002080 A MXPA05002080 A MX PA05002080A
- Authority
- MX
- Mexico
- Prior art keywords
- muscarinic agonists
- processes
- same
- making
- hydroxyindan
- Prior art date
Links
- 239000000472 muscarinic agonist Substances 0.000 title 1
- PTIASGVLWNOMTD-FIRIVFDPSA-N N-[(1R,2R)-6-[[N-[2-(4-fluorophenyl)ethyl]-C-methylcarbonimidoyl]amino]-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-4-phenylbenzamide Chemical compound FC1=CC=C(CCNC(C)=NC2=CC=C3C[C@H]([C@@H](C3=C2)NC(=O)C2=CC=C(C=C2)C2=CC=CC=C2)O)C=C1 PTIASGVLWNOMTD-FIRIVFDPSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40544302P | 2002-08-22 | 2002-08-22 | |
| PCT/US2003/023260 WO2004018411A1 (en) | 2002-08-22 | 2003-08-12 | Muscarinic agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05002080A true MXPA05002080A (es) | 2005-08-18 |
Family
ID=31946873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05002080A MXPA05002080A (es) | 2002-08-22 | 2003-08-12 | Agonistas muscarinicos. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7160922B2 (https=) |
| EP (1) | EP1534667B1 (https=) |
| JP (1) | JP4469280B2 (https=) |
| CN (1) | CN100554247C (https=) |
| AR (1) | AR040889A1 (https=) |
| AT (1) | ATE491683T1 (https=) |
| AU (1) | AU2003256791B2 (https=) |
| BR (1) | BR0313161A (https=) |
| CA (1) | CA2493958C (https=) |
| CY (1) | CY1111115T1 (https=) |
| DE (1) | DE60335380D1 (https=) |
| DK (1) | DK1534667T3 (https=) |
| ES (1) | ES2355213T3 (https=) |
| MX (1) | MXPA05002080A (https=) |
| PE (1) | PE20040894A1 (https=) |
| PT (1) | PT1534667E (https=) |
| SI (1) | SI1534667T1 (https=) |
| TW (1) | TW200410922A (https=) |
| WO (1) | WO2004018411A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2013523679A (ja) | 2010-03-29 | 2013-06-17 | ビーエーエスエフ ソシエタス・ヨーロピア | 殺菌性イミノ誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA76492C2 (en) * | 2001-09-21 | 2006-08-15 | Lilly Co Eli | Muscarinic agonists, a pharmaceutical composition on their basis |
-
2003
- 2003-08-12 DE DE60335380T patent/DE60335380D1/de not_active Expired - Lifetime
- 2003-08-12 JP JP2004530846A patent/JP4469280B2/ja not_active Expired - Fee Related
- 2003-08-12 AU AU2003256791A patent/AU2003256791B2/en not_active Ceased
- 2003-08-12 CA CA2493958A patent/CA2493958C/en not_active Expired - Fee Related
- 2003-08-12 EP EP03792989A patent/EP1534667B1/en not_active Expired - Lifetime
- 2003-08-12 US US10/524,960 patent/US7160922B2/en not_active Expired - Fee Related
- 2003-08-12 BR BR0313161-0A patent/BR0313161A/pt not_active IP Right Cessation
- 2003-08-12 DK DK03792989.0T patent/DK1534667T3/da active
- 2003-08-12 CN CNB038192500A patent/CN100554247C/zh not_active Expired - Fee Related
- 2003-08-12 PT PT03792989T patent/PT1534667E/pt unknown
- 2003-08-12 SI SI200331933T patent/SI1534667T1/sl unknown
- 2003-08-12 WO PCT/US2003/023260 patent/WO2004018411A1/en not_active Ceased
- 2003-08-12 AT AT03792989T patent/ATE491683T1/de active
- 2003-08-12 MX MXPA05002080A patent/MXPA05002080A/es active IP Right Grant
- 2003-08-12 ES ES03792989T patent/ES2355213T3/es not_active Expired - Lifetime
- 2003-08-20 TW TW092122893A patent/TW200410922A/zh unknown
- 2003-08-20 AR AR20030103011A patent/AR040889A1/es unknown
- 2003-08-21 PE PE2003000851A patent/PE20040894A1/es not_active Application Discontinuation
-
2011
- 2011-01-19 CY CY20111100057T patent/CY1111115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2493958A1 (en) | 2004-03-04 |
| WO2004018411A1 (en) | 2004-03-04 |
| CN1675173A (zh) | 2005-09-28 |
| BR0313161A (pt) | 2005-06-14 |
| ES2355213T3 (es) | 2011-03-23 |
| CY1111115T1 (el) | 2015-06-11 |
| JP2005536549A (ja) | 2005-12-02 |
| PE20040894A1 (es) | 2004-11-25 |
| CN100554247C (zh) | 2009-10-28 |
| AR040889A1 (es) | 2005-04-20 |
| DK1534667T3 (da) | 2011-02-14 |
| DE60335380D1 (de) | 2011-01-27 |
| US7160922B2 (en) | 2007-01-09 |
| TW200410922A (en) | 2004-07-01 |
| EP1534667B1 (en) | 2010-12-15 |
| JP4469280B2 (ja) | 2010-05-26 |
| EP1534667A1 (en) | 2005-06-01 |
| AU2003256791A1 (en) | 2004-03-11 |
| ATE491683T1 (de) | 2011-01-15 |
| AU2003256791B2 (en) | 2008-12-11 |
| US20060122280A1 (en) | 2006-06-08 |
| CA2493958C (en) | 2010-11-09 |
| SI1534667T1 (sl) | 2011-02-28 |
| PT1534667E (pt) | 2011-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07196A1 (en) | Potentiators of glutamate receptors | |
| PL372799A1 (en) | New compounds | |
| WO2003074500A3 (en) | N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors | |
| PL376524A1 (pl) | Nowe hydroksyindole, ich zastosowanie jako inhibitorów fosfodiesterazy 4 i sposób ich wytwarzania | |
| AU2003295705A1 (en) | B-stageable die attach adhesives | |
| AU2003228770A1 (en) | Substituted pyrazolopyrimidines | |
| MXPA03011197A (es) | Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales. | |
| CL2010000204A1 (es) | Compuestos intermediarios derivados de 4 amino-3-metoxibenzamida; compuesto intermediario n-{4-[4-(ciclopropilmetil)piperazin-1-il]ciclohexil}acetamida; compuesto intermediario 2-cloro-7-etil-7,8-dihidro-5-metil-8-(1-metiletil)-6(5h)-pteridinona, útiles en la preparación de dihidropteridinonas sustituidas (divisional sol. 2077-05). | |
| WO2005005679A3 (en) | Super-hydrophobic surfaces, methods of their construction and uses therefor | |
| DK1543002T3 (da) | Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter | |
| WO2006116127A3 (en) | Compositions for use in identification of bacteria | |
| TW200624426A (en) | BACE inhibitors | |
| AU2002358390A1 (en) | Novel compounds | |
| UA85394C2 (ru) | Замещенные хинолины в качестве ингибиторов ферментов протеинтирозиновых киназ | |
| PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
| AP1766A (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. | |
| UA83648C2 (ru) | Антагонисты аденозиндифосфатного рецептора тромбоцитов | |
| WO2002040451A3 (en) | Lactam compound | |
| MXPA06000986A (es) | Compuestos. | |
| GB0322510D0 (en) | Novel compounds | |
| MXPA03007413A (es) | Composicion y metodo para tratar enfermedades inflamatorias. | |
| DK1363944T3 (da) | Höjaffinitetsantagonister for ELR-CXC-kemokiner | |
| MXPA05002080A (es) | Agonistas muscarinicos. | |
| HRP20051005A2 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
| PL366988A1 (en) | Gelling sugar and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |